Dana-Farber Cancer Institute: all 833 studies

Page 5 of 9. Open to participants first (121), then studies with results posted, then the rest; newest registration first within each.

• The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate CancerCompletedNCT00459186Phase 1/2Results posted
• Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and NeckCompletedNCT00459043Phase 2Results posted
• Imatinib in Patients With Mucosal or Acral/Lentiginous MelanomaCompletedNCT00424515Phase 2Results posted
• Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM)CompletedNCT00422799Phase 2Results posted
• Perifosine in Patients With Relapsed/Refractory Waldenstrom's MacroglobulinemiaCompletedNCT00422656Phase 2Results posted
• Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian CarcinomaTerminatedNCT00418093Phase 2Results posted
• RAD001 in Previously Treated Patients With Metastatic Pancreatic CancerCompletedNCT00409292Phase 2Results posted
• 05-001: Treatment of Acute Lymphoblastic Leukemia in ChildrenCompletedNCT00400946Phase 3Results posted
• Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric CancerCompletedNCT00394433Phase 2Results posted
• Rituximab for Prevention of Chronic GVHDCompletedNCT00379587Phase 1/2Results posted
• Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple MyelomaCompletedNCT00378209Phase 2Results posted
• Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple MyelomaActive, not recruitingNCT00378105Phase 1/2Results posted
• Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell TransplantationCompletedNCT00369226Phase 1/2Results posted
• Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive CancerCompletedNCT00357500Phase 2Results posted
• Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian CancerTerminatedNCT00322881Phase 2Results posted
• Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer PatientsCompletedNCT00317603Phase 1Results posted
• Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell TransplantationCompletedNCT00282282Phase 2Results posted
• Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms MacroglobulinemiaCompletedNCT00250926Phase 2Results posted
• Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium ThiosulfateTerminatedNCT00165503Phase 2Results posted
• Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With HemoglobinopathiesCompletedNCT00153985Phase 2Results posted
• Bortezomib (Velcade) in Patients With Untreated Multiple MyelomaCompletedNCT00153920Phase 2Results posted
• CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's MacroglobulinemiaTerminatedNCT00142168Phase 2Results posted
• A Study in Adults With Untreated Acute Lymphoblastic LeukemiaCompletedNCT00136435Phase 2Results posted
• Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric CancerCompletedNCT00130689Phase 2Results posted
• RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMASCompletedNCT00126672Phase 2Results posted
• Intensive Chemotherapy and Rituximab in the Treatment of Burkitt LymphomaTerminatedNCT00126191Phase 2Results posted
• Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's LymphomaCompletedNCT00117156Phase 2Results posted
• Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate CancerCompletedNCT00116142Phase 3Results posted
• Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or NeuroblastomaCompletedNCT00098865Phase 2Results posted
• Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)CompletedNCT00095875Phase 3Results posted
• Letrozole in Preventing Breast Cancer in Postmenopausal WomenCompletedNCT00090857Phase 2Results posted
• Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RTCompletedNCT00084838Phase 2Results posted
• Bladder Preservation or Cystectomy for MIBCActive, not recruitingNCT07821177Early Phase 1
• Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational InterventionCompletedNCT07519200Not applicable
• Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)WithdrawnNCT07513324Phase 2
• Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE TrialActive, not recruitingNCT07442578Not applicable
• Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness CommunicationActive, not recruitingNCT07147023Not applicable
• 177LuPSMA in Renal Cell CarcinomaActive, not recruitingNCT06964958Phase 2
• Deep Clinical Trajectory Modeling to Optimize Accrual to Cancer Clinical TrialsCompletedNCT06888089Not applicable
• Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)Active, not recruitingNCT06807294Not applicable
• Pilot of a Trial Enrollment Diversity DashboardCompletedNCT06795139Not applicable
• Dance Study for Post-surgical Pain in Breast Cancer SurvivorsActive, not recruitingNCT06758102Not applicable
• Integrating Pain-CBT Into an mHealth Analgesic Support Intervention for Patients With Chronic Pain From Advanced CancersCompletedNCT06722014Not applicable
• MyeloGen: Germline Testing for Predisposition to Myeloid MalignanciesWithdrawnNCT06543511Not applicable
• PRISM for Depression and Anxiety in Young Adults With CancerCompletedNCT06502483Not applicable
• Sexual Health and Rehabilitation Online (SHAREonline)Active, not recruitingNCT06458049Not applicable
• PediCARE Health Equity Intervention in High-Risk NeuroblastomaWithdrawnNCT06335745Not applicable
• Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)Active, not recruitingNCT06322888Not applicable
• Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial CarcinomaActive, not recruitingNCT06318871Early Phase 1
• LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate CancerActive, not recruitingNCT06303713Phase 1
• INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine TherapyCompletedNCT06246084Not applicable
• Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARDActive, not recruitingNCT06068075Not applicable
• Implantable Microdevice for TNBC - Pilot StudyWithdrawnNCT05774886Phase 1
• CAR- PRISM (PRecision Intervention Smoldering Myeloma)Active, not recruitingNCT05767359Phase 2
• Enhancing Information Management for Young Adults After Genetic Cancer Risk TestingActive, not recruitingNCT05759143Not applicable
• Pirtobrutinib and Venetoclax in Waldenström MacroglobulinemiaActive, not recruitingNCT05734495Phase 2
• STOP-HER2: Stopping Trastuzumab in HER2+ MBCActive, not recruitingNCT05721248Phase 2
• A Novel Intervention for Patients With CancerCompletedNCT05643027Not applicable
• Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)Active, not recruitingNCT05629065Not applicable
• UNTIRE: Cancer-related Fatigue With Digital TreatmentWithdrawnNCT05584540Not applicable
• Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)CompletedNCT05528263Not applicable
• The SPOT-HPV StudyCompletedNCT05524025
• Cardiotoxicities in Patients Receiving BTKiWithdrawnNCT05521178
• Home Transfusion for HEMECompletedNCT05509439Not applicable
• Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2WithdrawnNCT05482074Phase 2
• Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE StudyActive, not recruitingNCT05327452Not applicable
• Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART TrialActive, not recruitingNCT05236062Not applicable
• GROW (Glioma Specialists Reaching Out With Support) SupportWithdrawnNCT05233215Not applicable
• Video Education With Result Dependent dIsclosureCompletedNCT05225428Not applicable
• The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)Active, not recruitingNCT05121558Not applicable
• UPLYFT For Lymphoma SurvivorsCompletedNCT05080166Not applicable
• Marizomib Central Nervous System (CNS)WithdrawnNCT05050305Phase 2
• Venetoclax Plus Inotuzumab for B-ALLActive, not recruitingNCT05016947Phase 1
• Post-treatment Surveillance in HPV+ Oropharyngeal SCCActive, not recruitingNCT04965792
• Axillary Lymph Node Tattoo Marking StudyTerminatedNCT04947917Not applicable
• TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)CompletedNCT04936243Not applicable
• NeoVax + CDX-301 and Nivolumab or Pembrolizumab in MelanomaActive, not recruitingNCT04930783Phase 1
• The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)Active, not recruitingNCT04917796Not applicable
• Feasibility Pilot Exploring Variability in Biomarkers and PROs in AMLCompletedNCT04908852
• Acalabrutinib in CNSLActive, not recruitingNCT04906902Phase 1/2
• Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and EngagementCompletedNCT04879927Not applicable
• Survivor-Sleep Health Information ProgramCompletedNCT04863157Not applicable
• Dilute Bleach Compresses for Radiation DermatitisWithdrawnNCT04851522Early Phase 1
• Phase Ia/Ib Talazoparib + Tazemetostat for mCRPCActive, not recruitingNCT04846478Phase 1
• Safe Accelerated Venetoclax Escalation in CLLActive, not recruitingNCT04843904Phase 1
• ASP8374 + Cemiplimab in Recurrent GliomaCompletedNCT04826393Phase 1
• AWARENESS Trial (AWARENESS) of Storytelling Through Music in Healthcare WorkersCompletedNCT04775524Not applicable
• Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing ChemotherapyActive, not recruitingNCT04724499Not applicable
• Taking AIM at Breast CancerActive, not recruitingNCT04720209Not applicable
• Feasibility of Fasting & Exercise in Pts With HR+ MBCCompletedNCT04708860Not applicable
• Sargramostim (GM-CSF) + PD-1WithdrawnNCT04703426Phase 2
• Digitally Enhanced Smoking Cessation for High Risk SmokersActive, not recruitingNCT04691297Not applicable
• Cabozantinib With Topotecan-CyclophosphamideCompletedNCT04661852Phase 1
• Advance Care Planning: Communicating With Outpatients for Vital Informed DecisionCompletedNCT04660422
• Axi-cel in CNS LymphomaActive, not recruitingNCT04608487Phase 1
• Copanlisib Plus Venetoclax in R/R DLBCLActive, not recruitingNCT04572763Phase 1/2
• A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast CancerActive, not recruitingNCT04569747Phase 2
• My Mindful Moments: A Mindfulness Meditation and Digital Art ActivityCompletedNCT04557033Not applicable
• RESIST-ADT (Androgen Deprivation Therapy)CompletedNCT04485767Not applicable
• Intravenous Magnesium in Patients Receiving CisplatinCompletedNCT04481672Phase 1

← Dana-Farber Cancer Institute overview and focus areas